MX373524B - Solución estabilizada de ácido hipocloroso y uso de la misma. - Google Patents

Solución estabilizada de ácido hipocloroso y uso de la misma.

Info

Publication number
MX373524B
MX373524B MX2015016057A MX2015016057A MX373524B MX 373524 B MX373524 B MX 373524B MX 2015016057 A MX2015016057 A MX 2015016057A MX 2015016057 A MX2015016057 A MX 2015016057A MX 373524 B MX373524 B MX 373524B
Authority
MX
Mexico
Prior art keywords
hypochlorous acid
acid solution
stabilized hypochlorous
disclosed
antimicrobial solution
Prior art date
Application number
MX2015016057A
Other languages
English (en)
Spanish (es)
Other versions
MX2015016057A (es
Inventor
Robert Northey
Original Assignee
Sanfer Farma S A P I De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanfer Farma S A P I De C V filed Critical Sanfer Farma S A P I De C V
Publication of MX2015016057A publication Critical patent/MX2015016057A/es
Publication of MX373524B publication Critical patent/MX373524B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
MX2015016057A 2013-05-22 2014-05-22 Solución estabilizada de ácido hipocloroso y uso de la misma. MX373524B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361826382P 2013-05-22 2013-05-22
PCT/US2014/039202 WO2014190184A1 (en) 2013-05-22 2014-05-22 Stabilized hypochlorous acid solution and use thereof

Publications (2)

Publication Number Publication Date
MX2015016057A MX2015016057A (es) 2016-03-21
MX373524B true MX373524B (es) 2020-04-21

Family

ID=51934166

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015016057A MX373524B (es) 2013-05-22 2014-05-22 Solución estabilizada de ácido hipocloroso y uso de la misma.

Country Status (6)

Country Link
US (2) US9918477B2 (enExample)
EP (1) EP2999341B1 (enExample)
JP (1) JP6416227B2 (enExample)
CA (1) CA2913137A1 (enExample)
MX (1) MX373524B (enExample)
WO (1) WO2014190184A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007085018A2 (en) 2006-01-20 2007-07-26 Oculus Innovative Sciences, Inc. Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution
MX373524B (es) * 2013-05-22 2020-04-21 Sanfer Farma S A P I De C V Solución estabilizada de ácido hipocloroso y uso de la misma.
KR20200034722A (ko) 2017-06-28 2020-03-31 콜리디온, 인코포레이티드 세척, 소독 및/또는 살균을 위한 조성물, 방법 및 용도
WO2019140408A1 (en) 2018-01-14 2019-07-18 Collidion, Inc. Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating
EP3927351A4 (en) 2019-02-20 2023-01-04 Biiosmart Technologies LLC INTRAVENOUS HYPOCHLOROUS ACID SOLUTION, PREPARATION AND METHOD OF USE
LU101842B1 (en) 2020-06-08 2021-12-08 Arnaud Mainnemare Pharmaceutical Composition for treating or preventing lesions and infections in a mammal
US11097945B1 (en) 2020-11-04 2021-08-24 Cougar Creek Electrolysed Water, Llc Methods and systems for production of an aqueous hypochlorous acid solution
IT202000028082A1 (it) 2020-11-23 2022-05-23 Md Italy Srl Composizione, preparazione ed impiego di una miscela a base di bromo per l’igiene perioculare, il trattamento e la prevenzione delle blefariti

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1236398A4 (en) * 1999-12-10 2004-04-07 Kao Corp MICROBICIDAL COMPOSITIONS
JP3554749B2 (ja) * 2001-02-22 2004-08-18 株式会社アクシス 殺菌消毒剤
US9168318B2 (en) 2003-12-30 2015-10-27 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and methods of using the same
US20050139808A1 (en) 2003-12-30 2005-06-30 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and process for producing same
US20050196462A1 (en) 2003-12-30 2005-09-08 Oculus Innovative Sciences, Inc. Topical formulation containing oxidative reductive potential water solution and method for using same
EP1702161A2 (en) 2003-12-30 2006-09-20 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution, processes for producing same and methods of using the same
CN101163491B (zh) 2005-03-23 2017-04-19 奥古露丝创新科学公司 利用氧化还原电位水溶液治疗皮肤溃疡的方法
AU2006226750B2 (en) 2005-03-23 2012-07-19 Oculus Innovative Sciences, Inc. Method of treating skin ulcers using oxidative reductive potential water solution
MX2007013774A (es) 2005-05-02 2008-01-29 Oculus Innovative Sciences Inc Metodo para utilizar solucion de agua con potencial oxido reductor en aplicaciones dentales.
WO2007085018A2 (en) * 2006-01-20 2007-07-26 Oculus Innovative Sciences, Inc. Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution
JP6099294B2 (ja) 2007-03-13 2017-03-22 オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド 一酸化二塩素を含む抗菌溶液ならびにその製造方法および使用方法
CN102480972B (zh) * 2009-06-15 2014-12-10 奥古露丝创新科学公司 含有次氯酸的溶液及其使用方法
MX365380B (es) 2009-07-30 2019-05-31 Invekra S A P I De C V Formulacion de hidrogel que comprende agua con ppotencial de oxidacion-reduccion.
GB2488838A (en) * 2011-03-11 2012-09-12 Biomimetics Health Ind Ltd A stable antimicrobial aqueous hypochlorous acid solution
MX373524B (es) 2013-05-22 2020-04-21 Sanfer Farma S A P I De C V Solución estabilizada de ácido hipocloroso y uso de la misma.

Also Published As

Publication number Publication date
EP2999341A4 (en) 2016-11-02
JP2016521684A (ja) 2016-07-25
EP2999341A1 (en) 2016-03-30
MX2015016057A (es) 2016-03-21
EP2999341B1 (en) 2018-11-28
US20180206502A1 (en) 2018-07-26
US9918477B2 (en) 2018-03-20
CA2913137A1 (en) 2014-11-27
US20160120183A1 (en) 2016-05-05
WO2014190184A1 (en) 2014-11-27
US10412969B2 (en) 2019-09-17
JP6416227B2 (ja) 2018-10-31

Similar Documents

Publication Publication Date Title
MX373524B (es) Solución estabilizada de ácido hipocloroso y uso de la misma.
ZA202001717B (en) Compounds, salts thereof and methods for treatment of diseases
SA520411125B1 (ar) Nlrp مركبات وتركيبات لمعالجة حالات مرضية مرتبطة بنشاط
MX2018000396A (es) Compuestos aza sustituidos como inhibidores de cinasa 4 asociada al receptor de interleucina 1 (irak-4).
MX381417B (es) Inhibidores de glucosidasa.
EA201591612A1 (ru) ПРИМЕНЕНИЕ ПИРАЗОЛПИРИМИДИНОВЫХ ПРОИЗВОДНЫХ ДЛЯ ЛЕЧЕНИЯ НАРУШЕНИЙ, СВЯЗАННЫХ С PI3Kδ
CR20140537A (es) Compuesto heterocíclico nitrogenado
CY1122805T1 (el) Ενωσεις και μεθοδοι για την αγωγη βακτηριακων λοιμωξεων
BR112012001372A2 (pt) comprimido, e, métodos para preparar um comprimido e para a profilaxia ou tratamento de hiperfosfatemia.
EA201492040A1 (ru) Бициклически замещённые урацилы и их применение
BR112017007144A2 (pt) ácido valproico ou um sal farmaceuticamente aceitável do mesmo, composto, composição farmacêutica, e, composto ou composição para uso, uso, método ou composição.
WO2019040106A3 (en) COMPOUNDS, RELATED SALTS AND METHODS FOR THE TREATMENT OF DISEASES
EP2953624A4 (en) METHOD FOR THE TREATMENT OF MICROBIAL INFECTIONS, INCLUDING MASTITIS
BR112019001980A2 (pt) inibidor de ido1 e método de preparação e aplicação do mesmo
PH12020551126A1 (en) Modulation of heparin-binding epidermal growth factor activity for tympanic membrane healing
EA201591399A1 (ru) РАППγ АГОНИСТЫ ДЛЯ ЛЕЧЕНИЯ РАССЕЯННОГО СКЛЕРОЗА
HUE051295T2 (hu) Módosított fibroblaszt növekedési faktorok-1 szembetegségek kezelésére
EA201890476A1 (ru) ЗАМЕЩЕННЫЕ 1,2-ДИГИДРО-3H-ПИРРОЛО[1,2-c]ИМИДАЗОЛ-3-ОНЫ В КАЧЕСТВЕ АНТИБАКТЕРИАЛЬНЫХ СРЕДСТВ
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
WO2019040105A3 (en) COMPOUNDS, SALTS THEREOF AND METHODS FOR THE TREATMENT OF DISEASES
MX374354B (es) Método de curación de heridas.
MX384920B (es) Mejoras en y relacionadas con el tratamiento del agua, en particular para inhibir el crecimiento de microorganismos
MX374865B (es) Solución de diálisis.
BR112016014099A2 (pt) método de tratamento de feridas
WO2019040104A3 (en) COMPOUNDS, RELATED SALTS AND METHODS OF TREATING DISEASES

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: INVEKRA, S.A.P.I. DE C.V.

FG Grant or registration